Master The Supreme Court held that forcibly administering antipsychotic medication to a defendant during trial, without necessary findings of medical appropriateness and necessity, violated due process and fair trial rights. with this comprehensive case brief.
Riggins v. Nevada is a landmark Supreme Court decision at the intersection of criminal procedure, constitutional due process, and mental health law. It addresses when, if ever, the State may medicate a criminal defendant with antipsychotic drugs during trial over the defendant's objection. Because these medications can alter a defendant's appearance, demeanor, and cognitive functioning, the case spotlights how courtroom fairness depends not only on what evidence is admitted but also on how the defendant can present himself and assist in his own defense.
The Court built on Washington v. Harper's recognition of a significant liberty interest in avoiding the unwanted administration of antipsychotics and adapted those protections to the trial setting. Riggins requires trial courts to make on-the-record findings that forced medication is medically appropriate and necessary—considering less intrusive alternatives—before permitting it at trial. The decision both protects bodily integrity and safeguards core Sixth and Fourteenth Amendment trial rights, laying groundwork for later cases like Sell v. United States.
504 U.S. 127 (1992)
David Riggins was charged in Nevada state court with murder and robbery. While detained pretrial, he complained of hearing voices and was prescribed the antipsychotic drug Mellaril (thioridazine). As the case progressed, Riggins notified the court he would assert insanity/diminished capacity defenses and moved to suspend the drug's administration during trial so the jury could evaluate his true mental condition and so he could meaningfully participate in his defense. After a brief hearing, the trial court denied the motion and ordered that Riggins continue to receive antipsychotic medication throughout trial without making specific findings that medication was medically appropriate and essential or that no less intrusive alternative would suffice. Riggins proceeded to trial while medicated, was convicted of murder and robbery, and was sentenced to death. The Nevada Supreme Court affirmed. The U.S. Supreme Court granted certiorari to decide whether the State's involuntary administration of antipsychotic drugs during trial violated Riggins's constitutional rights.
Does the State violate a defendant's due process and fair trial rights by administering antipsychotic medication during trial over the defendant's objection without first making findings that the treatment is medically appropriate and necessary, considering less intrusive alternatives?
The Due Process Clause protects a significant liberty interest in freedom from the unwanted administration of antipsychotic drugs. The State may not administer such medication to a defendant during trial over his objection unless it demonstrates, and the court finds on the record, that (1) the treatment is medically appropriate; (2) it is necessary to further essential state interests (such as the safety of the defendant or others or the integrity of the trial process), and (3) less intrusive alternatives have been considered and found inadequate. Any order permitting involuntary medication must rest on case-specific findings sufficient to allow meaningful appellate review.
Yes. The State violated due process by medicating Riggins during trial without on-the-record findings of medical appropriateness and necessity and without considering less intrusive alternatives. The conviction and sentence were reversed and remanded.
The Court began by reaffirming that individuals possess a constitutionally protected liberty interest in avoiding forced administration of antipsychotic drugs, citing Washington v. Harper. Antipsychotics can have profound effects on a person's mind and body, including sedation and changes in affect, which may alter a defendant's demeanor, ability to communicate, and the jury's assessment of his mental state—especially where sanity or intent is disputed. These concerns implicate both due process and core Sixth Amendment trial rights, such as the right to consult with counsel, to be present in a meaningful way, and to present a defense. In the trial context, the State's interests—such as ensuring safety in the courtroom and maintaining an orderly, fair proceeding—can be important. But those interests do not automatically override a defendant's liberty interest. At a minimum, trial courts must make findings that the proposed treatment is medically appropriate and necessary to further those essential interests and that less intrusive alternatives would be ineffective. The Court analogized to Harper's standard for prison settings and concluded that equal or greater procedural rigor is required when medication would be administered at a criminal trial. Here, the trial court permitted medication throughout Riggins's trial without articulating why it was necessary, whether it was in his best medical interest, or why less restrictive options would not suffice. This absence of findings prevented meaningful appellate review and failed to ensure that the defendant's trial rights were protected. Given the plausible ways the medication could have influenced the jury's perception of Riggins's mental condition and his ability to assist counsel, the State could not show the error was harmless beyond a reasonable doubt. The Court therefore reversed and remanded. The Court expressly declined to adopt a categorical rule forbidding involuntary medication at trial; instead, it required rigorous, case-specific justification. It also left for another day the question of when, if ever, medication may be compelled solely to restore trial competence (later addressed in Sell v. United States).
Riggins sets the baseline constitutional framework for involuntary medication in the trial setting. It requires trial judges to make explicit, reviewable findings of medical appropriateness, necessity, and the inadequacy of less intrusive alternatives before allowing antipsychotic medication over a defendant's objection. For law students, Riggins is a pivotal due process and fair trial case that: (1) operationalizes bodily integrity principles from Harper in the courtroom, (2) highlights how medication can distort a jury's assessment of sanity and mens rea, and (3) anticipates the more detailed competency-restoration standard later announced in Sell. Practically, it instructs defense counsel to build a robust record and instructs courts that silent or perfunctory orders will not withstand constitutional scrutiny.
No. Riggins does not impose a categorical ban. It requires the State to prove—and the court to find on the record—that the medication is medically appropriate, necessary to further essential state interests (e.g., safety or trial integrity), and that less intrusive alternatives are inadequate. Without those findings, compelled medication violates due process.
Harper recognized a prisoner's liberty interest in avoiding forced antipsychotic medication and allowed involuntary treatment if the inmate is dangerous and treatment is in his medical interest, with procedural safeguards. Riggins applied and adapted those protections to the trial setting, demanding on-the-record findings before medicating a defendant during trial. Sell, decided later, provided a specific four-part test for medicating a defendant solely to restore competence to stand trial. Together, they form the core trilogy on involuntary antipsychotic medication.
Beyond the due process liberty interest, the Court emphasized Sixth Amendment concerns. Antipsychotic drugs can affect a defendant's demeanor, expression, and ability to think clearly and consult with counsel, potentially distorting the jury's evaluation of sanity, intent, and credibility. These effects can undermine the fairness and reliability of the adjudication.
The court must make case-specific findings that the medication is medically appropriate for the defendant, that it is necessary to further essential state interests (such as safety or maintaining a fair and orderly trial), and that less intrusive alternatives (e.g., different medications, dosage adjustments, monitoring, or security measures) would be ineffective. The record must be robust enough to permit meaningful appellate review.
The conviction is subject to reversal. In Riggins, the Supreme Court reversed and remanded because the State could not show the error was harmless beyond a reasonable doubt. Given the potential for medication to influence the jury's perception and the defendant's participation, harmlessness will be difficult to establish without thorough, contemporaneous findings.
Yes. Competency while medicated does not end the inquiry. Riggins requires separate findings justifying involuntary medication at trial, including medical appropriateness, necessity, and consideration of less intrusive alternatives, because the fairness of the trial and the defendant's liberty interest remain at stake.
Riggins v. Nevada underscores that courtroom fairness includes protecting a defendant's bodily integrity and the conditions under which he appears before the jury. When the State seeks to medicate a defendant over objection during trial, it must meet a demanding constitutional threshold: show medical appropriateness, prove necessity to advance essential state interests, and demonstrate that less intrusive measures will not work—all on the record.
For practitioners and students, the case is a reminder to litigate these questions early and thoroughly, to build an evidentiary record addressing medical need and alternatives, and to focus on how medication could affect mens rea, insanity defenses, and the defendant's ability to participate. Riggins remains essential reading for any analysis of forced medication, mental health defenses, and due process in criminal adjudication.
Need to cite this case?
Generate a perfectly formatted Bluebook citation in seconds.
Use our Bluebook Citation Generator →